Biotech Startups

Bioherent develops photonic biosensing technology for ultra-sensitive diagnostic detection of allergic and immunological responses. The company serves healthcare providers and patients needing faster, more accessible allergy and immunology diagnostics through proprietary light-based engineering.

2 investors

BioHeuris develops biotech tools using gene editing to improve weed control efficiency and crop production for farmers. The company works with seed companies, growers, and researchers to deploy genome-edited crop traits across soybean, cotton, and sorghum.

2 investors

BioImagene sells chemical compounds and reference standards, primarily for research and analytical purposes.

2 investors

BioKier develops oral products for managing lipids and glucose in type 2 diabetes and cardiometabolic disorders, designed to replicate the metabolic benefits of bariatric surgery through colon-targeted nutrient delivery. The company is a clinical-stage biotech pursuing regulatory approval via the 505(b)2 NDA pathway.

2 investors

Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.

2 investors

BiomeBank develops microbiome-based therapies aimed at restoring the gut microbial ecosystem, with a focus on conditions such as inflammatory bowel disease and Clostridioides difficile infection. The company operates a cGMP manufacturing facility in Adelaide and works with academic and hospital research partners on drug discovery and clinical development.

2 investors

Biomemory develops DNA-based data storage, operating an integrated platform spanning molecular biology, biochemistry, hardware, software, and industrial DNA production for long-term data archiving. Spun out of Sorbonne University and CNRS, it serves the data storage market across Europe and North America.

2 investors

Biomoneta develops air decontamination devices that use ZeBox technology to eliminate airborne pathogens and provide medical-grade sterility without ozone or harmful radiation. The company offers medical-grade and consumer-grade air purification systems for hospitals, healthcare facilities, and homes.

2 investors

Biophilica develops Treekind, a plastic-free, PU-free leather alternative made from lignocellulosic feedstocks sourced from urban parks, gardens, and inedible agricultural waste, along with a biobased adhesive. The company produces compostable, non-toxic materials for the leather-alternative and sustainable materials market.

2 investors

Biophytis is a clinical-stage biotechnology company developing drug candidates for age-related diseases and metabolic conditions, with a phase 2 trial in obesity. The company is publicly listed and raises capital from institutional investors to fund its clinical programs.

2 investors

BioRaptor provides a bioprocess data management platform that stores and analyzes biological metrics to help biotechnology teams move from trial-and-error to optimized experimentation. The platform serves bioprocessing teams in R&D, scale-up, and production by making scientific data connected, contextualized, and actionable.

2 investors

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration. The company manufactures and sells biomimetic tissue repair and regeneration products for clinical use globally.

2 investors

Biorelate provides AI-led biomedical data curation for the biopharma industry, extracting cause-and-effect evidence from scientific literature to support drug discovery. It serves biotechs, pharmaceutical companies, data scientists, and computational biologists through its Galactic AI platform.

2 investors

BioRock Ventures is a seed-stage venture capital fund that invests in private life science startups developing novel FDA-regulated therapeutic drugs across all disease areas and modalities. It makes angel, seed, and Series A investments through to pre-IPO/M&A, based in the San Francisco Bay Area.

2 investors

Biosight was a pharmaceutical company that merged with Ayala Pharmaceuticals on October 19, 2023.

2 investors

Bioskryb provides genomic sequencing and single-cell analysis solutions for biopharmaceutical companies and clinical researchers, enabling them to characterize circulating tumor cells, identify biomarkers, and support drug development across oncology, neurology, and cell/gene editing applications.

2 investors

EcoBiotaX develops a microbial ecology platform that uses AI (its ecoSat computational platform) and biological methods to discover and construct natural bacterial communities for specific biological functions. It targets applications in health, food, agriculture, and climate.

2 investors

Biotheryx is a clinical-stage biopharmaceutical company developing first-in-class targeted protein degraders, including molecular glues and bifunctional degraders, with an initial focus on cancer and inflammatory disease. Its drug discovery work is built on modulating Cereblon and its proprietary PRODEGY platform.

2 investors

BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain. The company's offerings have anti-inflammation and anti-scarring properties and are used by surgeons and healthcare professionals to help patients heal faster.

2 investors

Biotts develops proprietary drug products and transdermal delivery systems for pharmaceutical applications, with a focus on improving patient quality of life.

2 investors

biotx.ai maps how genes causally shape human biology by systematically testing every human gene across tissues using large-scale Mendelian randomization, colocalization, and causal AI. This generates high-confidence causal links between genes, diseases, and biomarkers for drug target discovery.

2 investors

BIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development. Its work spans recombinant proteins, viral vectors, mRNA vaccines, and pharmaceutical process development for the biotech and pharmaceutical industries.

2 investors

BioVersys is a clinical-stage biotech company focused on developing antimicrobial therapies to address unmet medical needs in infectious diseases, including tuberculosis and hospital-acquired infections. The company targets infectious disease indications with next-generation antimicrobial treatments.

2 investors

Biovox works with PLA (polylactic acid), a biobased polymer, and evaluates its use as a material for drug delivery devices such as autoinjectors. The company focuses on sustainable material solutions for medical/pharmaceutical device applications.

2 investors